Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology
about
Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosisAntitubercular therapy decreases nitric oxide production in HIV/TB coinfected patientsThe emerging role of gasotransmitters in the pathogenesis of tuberculosisComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesNovel adjunctive therapies for the treatment of tuberculosisTuberculosis: latency and reactivationAcylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannanManual therapy as an effective treatment for fibrosis in a rat model of upper extremity overuse injuryDifferences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissueHypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operonDeletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosisRelation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitusMacrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infectionTumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice.Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungsFinding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity.In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.Genetic polymorphisms in TNF genes and tuberculosis in North Indians.Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsMycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.TNF-α Antagonist and Infection in Rheumatoid Arthritis.Posttreatment reactivation of tuberculosis in mice caused by Mycobacterium tuberculosis disrupted in mce1R.Reactivation of M. tuberculosis infection in trans-membrane tumour necrosis factor mice.DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge.Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis.Latent tuberculosis infection: myths, models, and molecular mechanismsAssociation between tumor necrosis factor alpha-238G/a polymorphism and tuberculosis susceptibility: a meta-analysis study.Protection against tuberculosis: cytokines, T cells, and macrophages.Human granuloma in vitro model, for TB dormancy and resuscitation.Innate immunity to Mycobacterium tuberculosis.How tumour necrosis factor blockers interfere with tuberculosis immunity.Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.Immunology studies in non-human primate models of tuberculosisMycobacterium tuberculosis culture filtrate protein 10-specific effector/memory CD4⁺ and CD8⁺ T cells in tubercular pleural fluid, with biased usage of T cell receptor Vβ chains.
P2860
Q21256673-C8D2AE36-3AD9-4297-8ECF-F3B963F96CE3Q24799192-E3A30C76-E3CF-439E-8064-EB1F030B9BA1Q26744038-7AFAAAB0-FC08-4AE5-8D57-47F007E1DE30Q26779956-64475A73-76EB-441B-8623-A8BB5EC11012Q26799747-DD0F1711-AF04-4B8C-923A-27E176011FF7Q26829957-9A3FCB2B-1D00-4EE4-B7BD-248A1888AC6FQ28201426-039D4527-96D7-4C87-8A18-541F5A99A15AQ28235685-5EAFC735-6DF8-44DE-816F-1222B8B6B4A8Q28385100-59DCC00C-7E12-447A-9D33-695EB3C6AF6BQ28469340-B82705DE-96B5-4E63-AC93-6A730E269DFBQ28486470-A41C3174-587C-4923-832C-228AB6E2ECCFQ28486566-3FE37318-17FE-4B96-9FCE-2984DF6F1D91Q28535244-8EFB6BA2-F8AD-4A2B-93C5-721D2B94814CQ28652447-5349D6CD-B226-484D-A251-B0D9550CD58FQ30502462-890FE616-7C34-4B94-86CF-6EDA13D2A9ABQ33310758-056B0E2A-3BE6-4C4D-942E-26C66F0613AAQ33315753-CED0770E-6B04-4FD5-BE4D-E68E9F9FAD03Q33519070-3E325D26-2429-4185-A0FF-1FA22541080CQ33573396-0580DB66-6C48-49A8-8F9D-BC01E76C5F12Q33600361-6A53467D-480B-408C-9B5B-F7D3313FB6C2Q33627062-0AAD69DC-298C-442A-8F04-126CC14FB008Q33809045-86838FCC-BE78-4DF0-8958-6C8357C13A6DQ33811658-781528DD-6176-409A-BE1F-EEB6DF959F6FQ33826578-01DC0A99-41B5-42DE-B1DA-A241FE9864BEQ33872130-568F48BC-0730-4FC4-8D15-BD5D37C5A172Q34047894-C29F8729-CB2C-4235-86D9-7103D1F776AAQ34087566-0E7CC1BE-56BF-4721-A9DE-E1F280D6A219Q34124601-8CBCB940-9E56-4F53-B72D-79B4092E5493Q34225956-1FC5E66F-6DAA-432C-A377-CB2CC8AAD654Q34286974-E6492871-F469-4060-BCD2-1E1B040F7D7FQ34297816-B026E56B-D98A-4EB0-9711-00D4FC6C6F78Q34494808-16A70AF2-9032-4C6A-A47F-3617F0D9A190Q34528163-3A108178-555A-4A7C-8356-2BD4848B71F9Q34545296-2B5485E2-CA4B-4D8C-B77D-A2A31283EF5EQ34587177-13E17113-BCF2-4AAF-865A-199E527BEE07Q34660051-11F40255-9548-42CB-B07F-FCB3DFDE2270Q35083799-4D48980E-92E4-4989-8605-EBFA534C59DFQ35116471-57EB1D2A-426D-4042-A446-E7FBB5349D92Q35116998-44CEADEC-53C6-48C7-8BCB-7599F7A7DBACQ35139260-FE3A0ED7-6F04-496F-9BE0-645D16E41F84
P2860
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of tumor necrosis fact ...... le role for limiting pathology
@ast
Effects of tumor necrosis fact ...... le role for limiting pathology
@en
Effects of tumor necrosis fact ...... le role for limiting pathology
@nl
type
label
Effects of tumor necrosis fact ...... le role for limiting pathology
@ast
Effects of tumor necrosis fact ...... le role for limiting pathology
@en
Effects of tumor necrosis fact ...... le role for limiting pathology
@nl
prefLabel
Effects of tumor necrosis fact ...... le role for limiting pathology
@ast
Effects of tumor necrosis fact ...... le role for limiting pathology
@en
Effects of tumor necrosis fact ...... le role for limiting pathology
@nl
P2093
P2860
P1476
Effects of tumor necrosis fact ...... le role for limiting pathology
@en
P2093
C A Scanga
K E Tanaka
P2860
P304
P356
10.1128/IAI.69.3.1847-1855.2001
P407
P577
2001-03-01T00:00:00Z